Phase II study of maytansine in advanced sarcomas

Cancer Treat Rep. 1983 Apr;67(4):401-2.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Maytansine / adverse effects
  • Maytansine / therapeutic use*
  • Middle Aged
  • Neoplasm Metastasis
  • Oxazines / therapeutic use*
  • Sarcoma / drug therapy*

Substances

  • Oxazines
  • Maytansine